MATTHIAS
DROSTEN
Investigador
Gustave Roussy Cancer Campus
Villejuif, FranciaGustave Roussy Cancer Campus-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2017
-
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Nature, Vol. 548, Núm. 7666, pp. 234-238